QA: Kura Oncology Inc. in us_pharma/2020

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001422143_2021_Kura_Oncology_Inc.pdf

Logs

warning Missing logo subcommand.report {}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001422143')"}

Graph

Absolute values for 0001422143, Kura Oncology Inc.

  xvar xval
0 AssetsCurrent 637,292,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 2,021,000
3 remainder_Assets 7,899,000
4 LiabilitiesCurrent 26,024,000
5 LiabilitiesNoncurrent 10,283,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 31,502,000
9 ResearchAndDevelopmentExpense 60,397,000
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 2,274,000
13 remainder_ComprehensiveNetIncome -285,000
  yvar yval
0 Assets 647,212,000
1 Liabilities 36,307,000
2 Expenses 91,899,000
3 Revenues 0
4 StockholdersEquity 610,905,000
5 NetIncome -89,625,000
6 ComprehensiveNetIncome -89,767,500
7 BaseVar 388,988,500
8 EconomicCapitalRatio 2.81

Edgar->Model Mapping

Feature Distribution

Change over Time